AI
Tuesday, September 18, 2012 7:51:51 AM
SYN. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
-- Acinetobacter Infections Pose Growing Concern in Hospitals, and in Military and Natural Disaster Trauma Centers --
-- Company Engages Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive to Provide Expertise on Advancing Infectious Disease Pipeline --
http://finance.yahoo.com/news/synthetic-biologics-initiates-development-monoclonal-110000638.html
-- Acinetobacter Infections Pose Growing Concern in Hospitals, and in Military and Natural Disaster Trauma Centers --
-- Company Engages Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive to Provide Expertise on Advancing Infectious Disease Pipeline --
http://finance.yahoo.com/news/synthetic-biologics-initiates-development-monoclonal-110000638.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
